<< Back to News
System Formulary Update
Intraocular Viscoelastics Standardization
Situation
The intraocular viscoelastics standardization was approved at the System Pharmacy and Therapeutics Committee meeting.
Background
The following therapeutic interchange was reviewed: Amvisc, Amvisc Plus, DisCoVisc, OcuCoat, Provisc, Viscoat, Duovisc, Healon5 Pro, Healon EndoCoat, and Healon Duet
Assessment/ Recommendations:
System P&T voted to include the following products on the UNC Health System Drug Formulary:
- Sodium hyaluronate
- Intraocular solution: 10 mg/mL (0.55 mL, 0.85 mL), 12 mg/mL (0.8 mL), 16 mg/mL (0.8 mL), 23 mg/mL (0.6 mL), 30 mg/mL (0.85 mL)
- Sodium chondroitin-hyaluronate
- intraocular solution: 40 mg/mL- 30 mg/mL (0.5 mL), 40 mg/mL-17 mg/mL (1mL)
- intraocular kits: 0.35 mL-0.4 mL (Duovisc), 0.55 mL-0.85 mL (Healon Duet)
- Hydroxypropyl methylcellulose
- Intraocular solution: 2% (1 mL)
Excluded from UNC Health System Drug Formulary |
Included in UNC Health System Drug Formulary
|
- Chondroitin Sulfate -Sodium Hyaluronate 3%-5% (0.5 mL) 1% (0.55 mL) IO Syringe (Duovisc)
- Sodium Hyaluronate 14 mg/mL IO Syringe (Healon GV)
- Chondroitin Sulfate-Sodium Hyaluronate 40-30 mg/mL IO Syringe 0.75 mL (Viscoat)
|
- Chondroitin Sulfate-Sodium Hyaluronate 40-17 mg/mL IO Syringe (Discovisc)
- Chondroitin Sulfate-Sodium Hyaluronate 40-30 mg/mL IO Syringe 0.5 mL (Viscoat)
- Chondroitin Sulfate -Sodium Hyaluronate 3%-5% (0.35 mL) 1% (0.4 mL) IO Syringe (Duovisc)
- Sodium Hyaluronate 10 mg/mL IO Syringe (Provisc)
- 0.55 mL size
- 0.85 mL size
- Sodium Hyaluronate 12 mg/mL IO Syringe (Amvisc)
- Sodium Hyaluronate 16 mg/mL IO Syringe (Amvisc Plus)
- Sodium Hyaluronate 23 mg/mL IO Syringe (Healon5 Pro)
- Sodium Hyaluronate 30 mg/mL IO Syringe (Healon Endocoat)
- Sodium Hyaluronate-Sodium Hyaluronate 10 mg/mL (0.55 mL)-30mg/mL (0.85 mL) IO Syringe Kit (Healon Duet)
- Hypromellose 2% IO Syringe (Ocucoat)
|
Formulary/Epic changes will Go-Live on Tuesday, September 10, 2024.